Dr. James H. Revkin, MD

Dr. Revkin practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Revkin's NPI, 1730178591, was assigned on October 14, 2005. Dr. Revkin holds Massachusetts license 291232.

Dr. Revkin's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Revkin's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Revkin is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Revkin to 3 more hospitals, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Revkin practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Revkin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Revkin's licenses on file in 2 states: Massachusetts and Connecticut.

CMS data shows 1,359 Medicare services from Dr. Revkin across 6 procedure codes in 2024, for 877 Medicare patients. Medicare paid $37,528 for them.

CMS counts 877 Medicare patients who saw Dr. Revkin in 2024. The largest group is 75 to 84, with 334 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Revkin's median patient age at 54, with 59% women.

In 2024, Dr. Revkin wrote 696 Medicare Part D claims for 152 patients. 89% of them were for generic drugs. CMS names the drug for 494 of them, across 14 drugs with 11 or more claims each, at $35,181 in total drug cost.

Dr. Revkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Revkin as offering telehealth.

Dmand AI links 17 papers to Dr. Revkin, published from 2010 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Anticholesteremic Agents and Cardiovascular Diseases. Dr. Revkin has published most often in Am Heart J. Dr. Revkin's most frequent co-authors are Paul M. Ridker, MD, Steven E. Nissen, MD and Philip D. Bonomi, MD.

CMS Open Payments shows 2 general payments to Dr. Revkin from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $95. It also lists 10 research payments totaling $20,090 in 2023.